Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer

NCT06938724 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
152
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano